Literature DB >> 12709305

Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders.

Pierre Sokoloff1, Olivier Guillin, Jorge Diaz, Patrick Carroll, Nathalie Griffon.   

Abstract

Brain-derived neurotrophic factor (BDNF) belongs to a family of proteins related to nerve growth factor, which are responsible for neuron proliferation, survival and differentiation. A more diverse role for BDNF as a neuronal extracellular transmitter has, nevertheless, been proposed. The dopamine D(3) receptor has been implicated in neuropsychiatric disorders including schizophrenia, drug addiction, depression and Parkinson's disease. Its expression during development and in adulthood is highly dependent on dopaminergic innervation. Here we show that BDNF synthesized by dopamine neurons is responsible for the appearance of the D(3) receptor during development and maintains D(3) receptor expression in adults. Moreover, BDNF triggers D(3) receptor overexpression and behavioral sensitization to levodopa in denervated animals. These results suggest that BDNF, by controlling the expression of specific genes such as the D(3) receptor gene, may be an important factor in neurodevelopmental psychiatric diseases.

Entities:  

Year:  2002        PMID: 12709305     DOI: 10.1080/1029842021000045499

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  72 in total

1.  Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain.

Authors:  K P Das; S L Chao; L D White; W T Haines; G J Harry; H A Tilson; S Barone
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 2.  Neurotransmitters as growth regulatory signals: role of receptors and second messengers.

Authors:  J M Lauder
Journal:  Trends Neurosci       Date:  1993-06       Impact factor: 13.837

3.  Prenatal D1, D1b and D3 dopamine receptor gene expression in the rat forebrain: detection by reverse polymerase chain reaction.

Authors:  M A Cadoret; M Jaber; B Bloch
Journal:  Neurosci Lett       Date:  1993-05-28       Impact factor: 3.046

4.  Neurotrophins induce formation of functional excitatory and inhibitory synapses between cultured hippocampal neurons.

Authors:  C Vicario-Abejón; C Collin; R D McKay; M Segal
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

5.  Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients.

Authors:  M Takahashi; O Shirakawa; K Toyooka; N Kitamura; T Hashimoto; K Maeda; S Koizumi; K Wakabayashi; H Takahashi; T Someya; H Nawa
Journal:  Mol Psychiatry       Date:  2000-05       Impact factor: 15.992

6.  BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.

Authors:  O Guillin; J Diaz; P Carroll; N Griffon; J C Schwartz; P Sokoloff
Journal:  Nature       Date:  2001-05-03       Impact factor: 49.962

7.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

8.  Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus.

Authors:  Q Huang; D Zhou; K Chase; J F Gusella; N Aronin; M DiFiglia
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.

Authors:  D G Cole; L A Kobierski; C Konradi; S E Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

10.  Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.

Authors:  H L Ryoo; D Pierrotti; J N Joyce
Journal:  Mov Disord       Date:  1998-09       Impact factor: 10.338

View more
  13 in total

1.  Effects of risperidone on dopamine receptor subtypes in developing rat brain.

Authors:  Taylor Moran-Gates; Christopher Grady; Young Shik Park; Ross J Baldessarini; Frank I Tarazi
Journal:  Eur Neuropsychopharmacol       Date:  2006-12-18       Impact factor: 4.600

2.  Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.

Authors:  Diana Alarcón-Arís; Ariadna Recasens; Mireia Galofré; Iria Carballo-Carbajal; Nicolás Zacchi; Esther Ruiz-Bronchal; Rubén Pavia-Collado; Rosario Chica; Albert Ferrés-Coy; Marina Santos; Raquel Revilla; Andrés Montefeltro; Isabel Fariñas; Francesc Artigas; Miquel Vila; Analia Bortolozzi
Journal:  Mol Ther       Date:  2017-11-29       Impact factor: 11.454

3.  Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking.

Authors:  Undine E Lang; Thomas Sander; Falk W Lohoff; Rainer Hellweg; Malek Bajbouj; Georg Winterer; Jürgen Gallinat
Journal:  Psychopharmacology (Berl)       Date:  2006-12-21       Impact factor: 4.530

4.  A functional fast scan cyclic voltammetry assay to characterize dopamine D2 and D3 autoreceptors in the mouse striatum.

Authors:  Francis K Maina; Tiffany A Mathews
Journal:  ACS Chem Neurosci       Date:  2010-03-12       Impact factor: 4.418

5.  Dopamine D2 agonist priming in intact and dopamine-lesioned rats.

Authors:  Richard M Kostrzewa; John P Kostrzewa; Przemyslaw Nowak; Rose A Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis.

Authors:  Vijay A Mittal; Andrew Smolen; Derek J Dean; Andrea L Pelletier; Jessica Lunsford-Avery; Ashley Smith
Journal:  Schizophr Res       Date:  2012-07-04       Impact factor: 4.939

7.  Differential regional and dose-related effects of asenapine on dopamine receptor subtypes.

Authors:  Frank I Tarazi; Taylor Moran-Gates; Erik H F Wong; Brian Henry; Mohammed Shahid
Journal:  Psychopharmacology (Berl)       Date:  2008-02-24       Impact factor: 4.530

8.  REM sleep deprivation reverses neurochemical and other depressive-like alterations induced by olfactory bulbectomy.

Authors:  Maira J Maturana; Cláudia Pudell; Adriano D S Targa; Laís S Rodrigues; Ana Carolina D Noseda; Mariana H Fortes; Patrícia Dos Santos; Cláudio Da Cunha; Sílvio M Zanata; Anete C Ferraz; Marcelo M S Lima
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

9.  The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease.

Authors:  Thomas Foltynie; Simon G J Lewis; Terry E Goldberg; Andrew D Blackwell; Bhaskar S Kolachana; Daniel R Weinberger; Trevor W Robbins; Roger A Barker
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

10.  The Role of MicroRNAs in Human Diseases.

Authors:  Ali M Ardekani; Mozhgan Moslemi Naeini
Journal:  Avicenna J Med Biotechnol       Date:  2010-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.